Enovix Corporation (NASDAQ:ENVX - Get Free Report) gapped up before the market opened on Monday. The stock had previously closed at $2.46, but opened at $2.81. Enovix shares last traded at $2.5640, with a volume of 3,463,392 shares changing hands.
Analysts Set New Price Targets
ENVX has been the topic of several recent analyst reports. B. Riley Financial cut their price objective on Enovix from $10.00 to $9.00 and set a "buy" rating on the stock in a report on Thursday, August 13th. William Blair lowered shares of Enovix from an "outperform" rating to a "market perform" rating in a report on Monday, August 17th. Canaccord Genuity Group reduced their price target on shares of Enovix from $15.00 to $10.00 and set a "buy" rating for the company in a research report on Friday, August 14th. TD Cowen raised shares of Enovix to a "hold" rating in a research note on Monday, October 5th. Finally, Loop Capital raised shares of Enovix to a "strong-buy" rating in a research note on Monday, August 17th. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, three have issued a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $11.77.
Read Our Latest Stock Analysis on ENVX
Enovix Stock Up 1.8%
The business's 50-day moving average price is $3.36 and its 200-day moving average price is $5.11. The company has a quick ratio of 9.37, a current ratio of 9.71 and a debt-to-equity ratio of 2.46. The firm has a market capitalization of $549.72 million, a PE ratio of -3.15 and a beta of 2.49.
Enovix (NASDAQ:ENVX - Get Free Report) last announced its quarterly earnings data on Wednesday, August 12th. The company reported ($0.13) EPS for the quarter, beating analysts' consensus estimates of ($0.15) by $0.02. The firm had revenue of $9.02 million for the quarter, compared to the consensus estimate of $8.43 million. Enovix had a negative net margin of 473.89% and a negative return on equity of 64.50%. The firm's revenue was up 20.8% on a year-over-year basis. During the same period in the previous year, the firm posted ($0.13) earnings per share. Enovix has set its Q3 2026 guidance at -0.170--0.130 EPS. As a group, equities research analysts predict that Enovix Corporation will post -0.80 EPS for the current fiscal year.
Hedge Funds Weigh In On Enovix
Hedge funds have recently modified their holdings of the stock. Caitong International Asset Management Co. Ltd acquired a new stake in shares of Enovix during the 4th quarter valued at about $30,000. Calamos Advisors LLC acquired a new position in Enovix in the first quarter worth approximately $60,000. Sequoia Financial Advisors LLC acquired a new position in Enovix in the second quarter worth approximately $61,000. Gateway Wealth Partners LLC bought a new position in Enovix during the first quarter valued at approximately $68,000. Finally, Wealthfront Advisers LLC raised its position in Enovix by 27.8% during the first quarter. Wealthfront Advisers LLC now owns 13,800 shares of the company's stock valued at $71,000 after acquiring an additional 3,001 shares in the last quarter. 50.92% of the stock is owned by institutional investors and hedge funds.
About Enovix
(
Get Free Report)
Enovix Corporation is a battery technology company developing lithium-ion batteries that use a silicon-based anode and a three-dimensional cell architecture. The company's design is intended to increase energy density while incorporating structural features designed to improve safety and cycle life compared with conventional lithium-ion batteries.
Enovix is focused initially on batteries for consumer electronics, including smartphones, wearable devices and other mobile products. It has also identified applications in industrial, medical, aerospace, defense and electric vehicle markets.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Enovix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enovix wasn't on the list.
While Enovix currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.